Cardiovascular risk assessment for primary prevention in Malawian HIV patients on ART: are measurements of glycated hemoglobin and lipids worth the effort?

AIDS. 2021 May 1;35(6):997-999. doi: 10.1097/QAD.0000000000002822.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases* / prevention & control
  • Glycated Hemoglobin / analysis
  • HIV Infections* / drug therapy
  • Heart Disease Risk Factors
  • Humans
  • Lipids
  • Primary Prevention
  • Risk Factors

Substances

  • Glycated Hemoglobin A
  • Lipids